Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapieHumansFluorouracilColorectal NeoplasmsBenzoquinonesCell Line
Enhancing colorectal cancer treatment with a triple therapy approach involving 5-fluorouracil, thymoquinone, Polygonum minus.
Kshidan Marim Abdullah Salem, Ibrahim Malami, Kim Wei Chan, Md Zuki Abu Bakar, Noorjahan Banu Mohammed Alitheen, Mohammed Alsubbi, Hamidu Ahmed, Ahmad Faizal Abdull Razis, Norsharina Ismail
Published: 202510.1016/j.biopha.2025.118729
Abstract
Colorectal cancer (CRC) remains a leading cause of cancer-related mortality globally, with chemoresistance to 5-fluorouracil (5-FU) and dose-limiting toxicities posing major therapeutic challenges. This study investigates the synergistic potential of…
Preview only. Read the full abstract at the source